ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus

被引:70
|
作者
Liu, Cheng [1 ,2 ,3 ]
Li, Yanfang [2 ]
Guan, Tianwang [2 ]
Lai, Yanxian [1 ]
Shen, Yan [2 ]
Zeyaweiding, Abudurexiti [3 ]
Zhao, Haiyan [3 ]
Li, Fang [3 ]
Maimaiti, Tutiguli [3 ]
机构
[1] South China Univ Technol, Guangzhou Peoples Hosp 1, Sch Med, Dept Cardiol, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Cardiol, Guangzhou 510180, Guangdong, Peoples R China
[3] Shufu Peoples Hosp, Dept Cardiol, Kashgar Region 844100, Xinjiang Uygur, Peoples R China
来源
CARDIOVASCULAR DIABETOLOGY | 2018年 / 17卷
关键词
Association; ACE2; polymorphism; Cardiovascular risk; Type 2 diabetes mellitus; Uygur; CONVERTING-ENZYME; 2; CORONARY-HEART-DISEASE; GENE POLYMORPHISMS; BLOOD-PRESSURE; ANGIOTENSIN-II; LIFE-STYLE; EVENTS; DYSLIPIDEMIA; MANAGEMENT; ADULTS;
D O I
10.1186/s12933-018-0771-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 2 diabetes mellitus (T2D), rapidly increasing to epidemic proportions, globally escalates cardiovascular disease risk. Although intensive interventions and comprehensive management of environmental risks factors for T2D are associated with reduced cardiovascular disease, such approaches are limited for individuals with high genetic T2D risk. In this study we investigated possible associations of ACE2 polymorphisms and cardiovascular risks in Uygur patients with T2D. Methods: 275 Uygur T2D patients and 272 non-diabetic Uygur individuals were enrolled as study participants. 14 ACE2 polymorphisms were genotyped by Matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Results: ACE2 SNP rs1978124, rs2048683, rs2074192, rs233575, rs4240157, rs4646156, rs4646188 and rs879922 were associated with T2D (all P <0.05). The 8 diabetic risk related ACE2 SNPs were further associated with diabetic related cardiovascular complications or events but exhibited heterogeneity as fellows: firstly, almost all diabetic risk related ACE2 SNPs (all P <0.05) were associated with increased SBP except rs1978124 and rs2074192, while rs2074192, rs4646188 and rs879922 were associated elevated DBP (all P <0.05). Secondly, SNP rs4646188 was not correlated with any type of dyslipidemia (TRIG, HDL-C, LDL-C or CHOL), and the other 7 diabetic risk related loci were at least correlated with one type of dyslipidemia (all P <0.05). In particular, rs879922 were simultaneously correlated with four type of dyslipidemia (all P <0.05). Thirdly, ACE2 SNP rs2074192 and rs879922 were associated with carotid arteriosclerosis stenosis (CAS) >= 50% (both P <0.05). Fourthly, ACE2 SNP rs2074192, rs4240157, rs4646188 and 879922 were associated with increased MAU (all P <0.05). In addition, ACE2 SNP rs2048683, rs4240157, rs4646156, rs4646188 and rs879922 were linked to heavier LVMI (all P <0.05), but only rs4240157, rs4646156 and rs4646188 were associated with lower LVEF (all P < 0.05). Conclusion: ACE2 SNP rs879922 may be a common genetic loci and optimal genetic susceptibility marker forT2D and T2D related cardiovascular risks in Uygurs.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus
    Cheng Liu
    Yanfang Li
    Tianwang Guan
    Yanxian Lai
    Yan Shen
    Abudurexiti Zeyaweiding
    Haiyan Zhao
    Fang Li
    Tutiguli Maimaiti
    Cardiovascular Diabetology, 17
  • [2] Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
    Pan, Yizhi
    Wang, Tianyi
    Li, Yanfang
    Guan, Tianwang
    Lai, Yanxian
    Shen, Yan
    Zeyaweiding, Abudurexiti
    Maimaiti, Tutiguli
    Li, Fang
    Zhao, Haiyan
    Liu, Cheng
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [3] The ACE2 G8790A Polymorphism: Involvement in Type 2 Diabetes Mellitus Combined with Cerebral Stroke
    Wu, Yan-Hui
    Li, Jia-Ying
    Wang, Chi
    Zhang, Li-Mei
    Qiao, Hong
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2017, 31 (02)
  • [4] Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang
    Luo, Yi
    Liu, Cheng
    Guan, Tianwang
    Li, Yanfang
    Lai, Yanxian
    Li, Fang
    Zhao, Haiyan
    Maimaiti, Tutiguli
    Zeyaweiding, Abudurexiti
    HYPERTENSION RESEARCH, 2019, 42 (05) : 681 - 689
  • [5] Cardiovascular risk in type 2 diabetes mellitus
    Hohberg, C.
    Roth, W.
    Luebben, G.
    Forst, T.
    Gauert, S.
    Karagiannis, F.
    Reimer, T.
    Gottschall, V.
    Pfuetzner, A.
    DIABETES STOFFWECHSEL UND HERZ, 2007, 16 (03): : 173 - 177
  • [6] The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19
    Bosso, Mira
    Thanaraj, Thangavel Alphonse
    Abu-Farha, Mohamed
    Alanbaei, Muath
    Abubaker, Jehad
    Al-Mulla, Fahd
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2020, 18 : 321 - 327
  • [7] Type 2 diabetes mellitus: cardiovascular risk and cardiac rehabilitation concerns. Part I
    Perez Yanez, C. Lazara M.
    Gutierrez Lopez, Alain
    Rodriguez Blanco, Suilbert
    CORSALUD, 2021, 13 (02): : 217 - 228
  • [8] Obesity Genotype Score and Cardiovascular Risk in Women With Type 2 Diabetes Mellitus
    He, Meian
    Cornelis, Marilyn C.
    Franks, Paul W.
    Zhang, Cuilin
    Hu, Frank B.
    Qi, Lu
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (02) : 327 - U370
  • [9] Apelin and ACE2 in cardiovascular disease
    Kalea, Anastasia Z.
    Batlle, Daniel
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (03) : 273 - 282
  • [10] A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project
    Vangjeli, Ciara
    Dicker, Patrick
    Tregouet, David-Alexandre
    Shields, Denis C.
    Evans, Alun
    Stanton, Alice V.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2011, 12 (04) : 504 - 509